Summary of Purpose
The present study will be conducted to assess the following research questions in real-life conditions in France: What are the patient and disease characteristics, comorbidities and treatment history in NVAF patients initiating a new Anticoagulant (AC) treatment, according to treatment currently available and prescribed (apixaban, other NOACs, VKAs), and are the AC-naive patient profiles different from one...Read More →
The following dates are available for this trial. Trial information last updated on 17 April 2017.
|1 Oct 2015||16 Mar 2016||1 Dec 2016||1 Dec 2016||1 Mar 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Cross-Sectional
- Sampling: Probability Sample
- Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:
- First line of the email MUST contain NCT# and Site #.
- For participation information at a USA site use a phone number below. For Site information outside USA please email: